Dermatology drugs

80 results
Sun Pharmaceutical Industries, Inc.
Usage: ABSORICA and ABSORICA LD are indicated for treating severe recalcitrant nodular acne in non-pregnant patients aged 12 and older, particularly when unresponsive to conventional therapies. A two-month waiting period is recommended before considering a second treatment course.
Almirall, LLC
Usage: ACZONE® (dapsone) Gel, 7.5% is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.
Galderma Laboratories, L.P.
Usage: AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.
Bausch Health US, LLC
Usage: ALTRENO® (tretinoin) lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients aged 9 and older.

Ameluz (aminolevulinic acid hydrochloride)

(aminolevulinic acid hydrochloride)
Biofrontera Inc.
Usage: AMELUZ is indicated for the lesion-directed and field-directed treatment of mild-to-moderate actinic keratoses on the face and scalp, used in conjunction with photodynamic therapy (PDT) with BF-RhodoLED® or RhodoLED® XL lamp.
Journey Medical Corporation
Usage: AMZEEQ is indicated for the topical treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and patients aged 9 years and older. It is not evaluated for infection treatment and should be used as directed to prevent drug resistance.

Analpram hc (hydrocortisone acetate and pramoxine hydrochloride)

(hydrocortisone acetate and pramoxine hydrochloride)
Sebela Pharmaceuticals Inc.
Usage: Topical corticosteroids are indicated for alleviating inflammation and itching associated with corticosteroid-responsive skin conditions.
Bausch Health US, LLC
Usage: ARAZLO® (tazarotene) lotion, 0.045% is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.
Methapharm, Inc
Usage: Asclera® (polidocanol) is indicated for the sclerotherapy of uncomplicated spider veins (≤1 mm) and reticular veins (1-3 mm) in the lower extremities. It has not been evaluated for use in varicose veins exceeding 3 mm in diameter.

Baxdela (delafloxacin meglumine)

(delafloxacin meglumine)
Melinta Therapeutics, LLC
Usage: BAXDELA is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) in adults caused by specific susceptible bacteria, including MRSA and MSSA. It should be used judiciously to prevent drug resistance and based on culture and susceptibility data when available.
  • ...